Prognostic assessment in superficial bladder cancer

[1]  F. Bosman,et al.  Cytogenetic analysis in transitional cell carcinoma of the bladder. , 1993, British journal of urology.

[2]  J. Schalken,et al.  Decreased E-cadherin immunoreactivity correlates with poor survival in patients with bladder tumors. , 1993, Cancer research.

[3]  N. Heney,et al.  Natural history of superficial bladder cancer. Prognostic features and long-term disease course. , 1992, The Urologic clinics of North America.

[4]  H. G. van der Poel,et al.  Quantitative light microscopy in urological oncology. , 1992, The Journal of urology.

[5]  W. Fair,et al.  Bacillus Calmette-Guerin therapy for superficial bladder cancer: a 10-year followup. , 1992, The Journal of urology.

[6]  T. Sugimura,et al.  Frequent association of p53 gene mutation in invasive bladder cancer. , 1992, Cancer research.

[7]  R. Sylvester,et al.  Prognostic factors in superficial bladder tumors , 1992 .

[8]  S. Hayward,et al.  Tumor enzymes and prognosis in transitional cell carcinoma of the bladder: prediction of risk of progression in patients with superficial disease. , 1991, The Journal of urology.

[9]  P. Scardino,et al.  A randomized trial of intravesical doxorubicin and immunotherapy with bacille Calmette-Guérin for transitional-cell carcinoma of the bladder. , 1991, The New England journal of medicine.

[10]  P. Burney,et al.  Survival with bladder cancer, evaluation of delay in treatment, type of surgeon, and modality of treatment. , 1991, BMJ.

[11]  H. Huland,et al.  Residual tumor discovered in routine second transurethral resection in patients with stage T1 transitional cell carcinoma of the bladder. , 1991, The Journal of urology.

[12]  U. Norming,et al.  Comparative histopathology and deoxyribonucleic acid flow cytometry of random mucosal biopsies in untreated bladder carcinoma. , 1991, The Journal of urology.

[13]  F. Torti,et al.  Adjuvant intravesicular pharmacotherapy for superficial bladder cancer. , 1991, Journal of the National Cancer Institute.

[14]  P. Green,et al.  Identification of p53 gene mutations in bladder cancers and urine samples. , 1991, Science.

[15]  M. Valsecchi,et al.  Prognostic factors analysis in clinical oncology: handle with care. , 1991, Annals of oncology : official journal of the European Society for Medical Oncology.

[16]  R A Risdon,et al.  Interpretation of biopsies of "normal" urothelium in patients with superficial bladder cancer. MRC Superficial Bladder Cancer Sub Group. , 1991, British journal of urology.

[17]  E. Solsona,et al.  Carcinoma in situ associated with superficial bladder tumor. , 1991, European urology.

[18]  P. A. van den Brandt,et al.  Prognostic significance of type IV collagen and laminin immunoreactivity in urothelial carcinomas of the bladder , 1990, Cancer.

[19]  M. Soloway,et al.  Initial evaluation and response criteria for patients with superficial bladder cancer. Report of a workshop. , 1990, British journal of urology.

[20]  F. Holmes,et al.  Analysis of bladder carcinoma by subsite. Cystoscopic location may have prognostic value , 1990, Cancer.

[21]  R Simon,et al.  Measures of explained variation for survival data. , 1990, Statistics in medicine.

[22]  M. Walsh,et al.  Transferrin receptor expression in primary superficial human bladder tumours identifies patients who develop recurrences. , 1990, British journal of urology.

[23]  D. Newling.  Intravesical therapy in the management of superficial transitional cell carcinoma of the bladder: the experience of the EORTC GU Group. , 1990, British Journal of Cancer.

[24]  M. Melamed,et al.  Enhanced bladder cancer detection with the Lewis X antigen as a marker of neoplastic transformation. , 1990, The Journal of urology.

[25]  L. Bourget,et al.  Clinical cancer progression in urinary bladder tumors evaluated by multiparameter flow cytometry with monoclonal antibodies. Laval University Urology Group. , 1990, Cancer research.

[26]  J. Flamm,et al.  Factors affecting survival in primary superficial bladder cancer. , 1990, European urology.

[27]  Y. Collan,et al.  Volume corrected mitotic index (M/V index) in human bladder cancer; relation to histological grade (WHO), clinical stage (UICC) and prognosis. , 1990, Scandinavian journal of urology and nephrology.

[28]  J. Eble,et al.  Benign and low-grade papillary lesions of the urinary bladder: a review of the papilloma-papillary carcinoma controversy, and a report of five typical papillomas. , 1989, Seminars in diagnostic pathology.

[29]  L S Freedman,et al.  Prognostic factors for recurrence and followup policies in the treatment of superficial bladder cancer: report from the British Medical Research Council Subgroup on Superficial Bladder Cancer (Urological Cancer Working Party). , 1989, The Journal of urology.

[30]  B. Norlén,et al.  Combination of blood group ABH antigen status and DNA ploidy as independent prognostic factor in transitional cell carcinoma of the urinary bladder. , 1989, British journal of urology.

[31]  P. Rosenbaum.  The Role of Known Effects in Observational Studies , 1989 .

[32]  Sander Greenland,et al.  Comment: Cautions in the use of preliminary‐test estimators , 1989 .

[33]  B. Czerniak,et al.  Flow cytometric measurements of DNA and other cell components in human tumors: a critical appraisal. , 1989, Human pathology.

[34]  P. Abel,et al.  Blood group antigen expression in frozen sections of presenting bladder cancer: 3-year prospective follow-up of prognostic value. , 1989, British journal of urology.

[35]  P. Jipp,et al.  Surveillance and M-VEC therapy monitoring of patients with advanced carcinoma of the urinary tract by TPA , 1989 .

[36]  J. Flamm,et al.  The significance of bladder quadrant biopsies in patients with primary superficial bladder carcinoma. , 1989, European urology.

[37]  F. Debruyne,et al.  Blood group isoantigen deletion and chromosomal abnormalities in bladder cancer. , 1988, The Journal of urology.

[38]  M. Melamed,et al.  Bacillus Calmette-Guérin therapy alters the progression of superficial bladder cancer. , 1988, Journal of Clinical Oncology.

[39]  W. Murphy,et al.  Transitional cell neoplasms of the urinary bladder. Can biologic potential be predicted from histologic grading? , 1987, Cancer.

[40]  V. Laudone,et al.  An overview of intravesical therapy for superficial bladder tumors. , 1987, The Journal of urology.

[41]  P. Rosenbaum.  The Role of a Second Control Group in an Observational Study , 1987 .

[42]  D. Rubin,et al.  Causal Inference in Retrospective Studies , 1987 .

[43]  G. Smith,et al.  Do normal mucosal biopsies predict prognosis in patients with transitional cell carcinoma of bladder treated by radical radiotherapy? , 1987, British journal of urology.

[44]  P. Bassi,et al.  Prognosis of bladder cancer. I. Risk factors in superficial transitional cell carcinoma. , 1987, European urology.

[45]  F. Algaba,et al.  Value of random endoscopic biopsy in the diagnosis of bladder carcinoma in situ. , 1987, European urology.

[46]  H. Wolf,et al.  Urothelial atypia concomitant with primary bladder tumour. Incidence in a consecutive series of 500 unselected patients. , 1987, Scandinavian journal of urology and nephrology.

[47]  P. Stewart,et al.  Prognostic significance of ABH antigenicity of mucosal biopsies in superficial bladder cancer. , 1986, The Journal of urology.

[48]  R. Elton,et al.  Superficial bladder cancer: intravesical chemotherapy and tumour progression to muscle invasion or metastases. , 1986, British journal of urology.

[49]  W. Catalona,et al.  Two courses of intravesical bacillus Calmette-Guerin for transitional cell carcinoma of the bladder. , 1986, The Journal of urology.

[50]  R. Weinstein,et al.  Pathology of superficial bladder cancer with emphasis on carcinoma in situ. , 1986, Urology.

[51]  V. Siskind.  The need for randomization in the study of intended effects. , 1985, Statistics in medicine.

[52]  N. B. Atkin,et al.  Cytogenetic study of ten carcinomas of the bladder: involvement of chromosomes 1 and 11. , 1985, Cancer genetics and cytogenetics.

[53]  D. Rubin,et al.  Constructing a Control Group Using Multivariate Matched Sampling Methods That Incorporate the Propensity Score , 1985 .

[54]  D. Rubin,et al.  The bias due to incomplete matching. , 1983, Biometrics.

[55]  D. Sackett,et al.  The Ends of Human Life: Medical Ethics in a Liberal Polity , 1992, Annals of Internal Medicine.

[56]  D. Rubin,et al.  Reducing Bias in Observational Studies Using Subclassification on the Propensity Score , 1984 .

[57]  F. Harrell,et al.  Regression modelling strategies for improved prognostic prediction. , 1984, Statistics in medicine.

[58]  P. Rosenbaum.  From Association to Causation in Observational Studies: The Role of Tests of Strongly Ignorable Treatment Assignment , 1984 .

[59]  M. Igawa,et al.  ABO (H) blood group antigens and carcinoembryonic antigens as indicators of malignant potential in patients with transitional cell carcinoma of the bladder. , 1984, The Journal of urology.

[60]  H. Huland,et al.  The value of histologic grading and staging, random biopsies, tumor and bladder mucosa blood group antigens, in predicting progression of superficial bladder cancer. , 1984, European urology.

[61]  R. Elton,et al.  Prognostic significance of biopsy results of normal-looking mucosa in cases of superficial bladder cancer. , 1983, British journal of urology.

[62]  S. Loening,et al.  Superficial bladder cancer: progression and recurrence. , 1983, The Journal of urology.

[63]  H. Wolf,et al.  UROTHELIAL DYSPLASIA CONCOMITANT WITH BLADDER TUMOURS AS A DETERMINANT FACTOR FOR FUTURE NEW OCCURRENCES , 1983, The Lancet.

[64]  S. Loening,et al.  Bladder cancer: factors affecting survival. , 1983, The Journal of urology.

[65]  R. Schade,et al.  The association of urothelial abnormalities with neoplasia: a 10-year followup. , 1983, The Journal of urology.

[66]  D. Rubin,et al.  The central role of the propensity score in observational studies for causal effects , 1983 .

[67]  M. Boon,et al.  Analysis of the performance of pathologists in the grading of bladder tumors. , 1983, Human pathology.

[68]  D. Rubin,et al.  Assessing Sensitivity to an Unobserved Binary Covariate in an Observational Study with Binary Outcome , 1983 .

[69]  H. Huland,et al.  The value of urinary cytology, serum and urinary carcinoembryonic antigen, rheumatoid factors, and urinary immunoglobulin concentration as tumor markers or prognostic factors in predicting progression of superficial bladder cancer. , 1983, European urology.

[70]  F. Harrell,et al.  Evaluating the yield of medical tests. , 1982, JAMA.

[71]  G. Prout,et al.  Ta and T1 bladder cancer: location, recurrence and progression. , 1982, British journal of urology.

[72]  W Lutzeyer,et al.  Prognostic parameters in superficial bladder cancer: an analysis of 315 cases. , 1982, The Journal of urology.

[73]  I. Ishiyama,et al.  Synthesis of ABH blood group substances in bladder tumours. , 1981, British journal of urology.

[74]  J. Summers,et al.  A 10-year analysis of chromosomes in non-invasive papillary carcinoma of the bladder. , 1981, The Journal of urology.

[75]  D. P. Byar.  Possibilities and Limitations of Observational Studies and Evaluation of Medical Data Bases , 1981 .

[76]  S. Loening,et al.  Analysis of bladder tumor recurrence in 178 patients. , 1980, Urology.

[77]  D. Lamm,et al.  Prediction of bladder tumor invasion with the mixed cell agglutination test. , 1980, The Journal of urology.

[78]  T. Hargreave,et al.  The role of multiple mucosal biopsies in the management of patients with bladder cancer. , 1979, British journal of urology.

[79]  M. Soloway,et al.  „NORMAL”︁ urothelium in patients with bladder cancer. A preliminary report from the national bladder cancer collaborative group a , 1979, Cancer.

[80]  N. Javadpour,et al.  Correlation of the cell surface antigens with stage and grade in cancer of the bladder. , 1979, The Journal of urology.

[81]  P. Nieh,et al.  Biopsy of apparently normal urothelium in patients with bladder carcinoma. , 1978, The Journal of urology.

[82]  M. Soloway,et al.  Serial multiple-site biopsies in patients with bladder cancer. , 1978, The Journal of urology.

[83]  P. Lange,et al.  Tissue blood-group antigens and prognosis in low stage transitional cell carcinoma of the bladder. , 1978, The Journal of urology.

[84]  N. Javadpour,et al.  The cell surface antigen A, B or O(H) as an indicator of malignant potential in stage A bladder carcinoma: preliminary report. , 1978, The Journal of urology.

[85]  A. Sandberg.  Chromosome markers and progression in bladder cancer. , 1977, Cancer research.

[86]  L. Koss,et al.  Nonpapillary carcinoma in situ and atypical hyperplasia in cancerous bladders: further studies of surgically removed bladders by mapping. , 1977, Urology.

[87]  A. Althausen,et al.  Non-invasive papillary carcinoma of the bladder associated with carcinoma in situ. , 1976, The Journal of urology.

[88]  G. Farrow,et al.  Morphological and clinical observations of patients with early bladder cancer treated with total cystectomy. , 1976, Cancer research.

[89]  W. Falor,et al.  Cytogenetic analysis: a potential index for recurrence of early carcinoma of the bladder. , 1976, The Journal of urology.

[90]  J. M. Decenzo,et al.  Antigenic deletion and prognosis of patients with stage A transitional cell bladder carcinoma. , 1975, The Journal of urology.

[91]  J. Richie,et al.  The clinical significance of carcinoma in situ of the bladder and its association with overt carcinoma. , 1974, The Journal of urology.

[92]  L. Koss,et al.  Mapping cancerous and precancerous bladder changes. A study of the urothelium in ten surgically removed bladders. , 1974, JAMA.

[93]  R. Schade,et al.  The association of urothelial atypism with neoplasia: its importance in treatment and prognosis. , 1973, The Journal of urology.

[94]  R B EISENBERG,et al.  Bladder tumors and associated proliferative mucosal lesions. , 1960, The Journal of urology.

[95]  M. Melicow,et al.  Intra-urothelial cancer: carcinoma in situ, Bowen's disease of the urinary system: discussion of thirty cases. , 1952, The Journal of urology.

[96]  M. Melicow.  Histological study of vesical urothelium intervening between gross neoplasms in total cystectomy. , 1952, The Journal of urology.

[97]  D.,et al.  Regression Models and Life-Tables , 2022 .